Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
86%(6 trials)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_1
2
25%
Ph phase_2
2
25%
Ph phase_4
2
25%
Ph phase_3
1
13%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A1 (12.5%)

Trials by Status

completed788%
withdrawn113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

Longitudinal Study of Brain Amyloid imaGing in MEMENTO

NCT02164643
completedphase_1

Florbetapir Calibration to the Centiloid Scale

NCT02120664
completedphase_4

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

NCT01703702
completedphase_4

The Feasibility of Florbetapir Quantitation in Europe

NCT02107599
withdrawnnot_applicable

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

NCT02029547
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02164643Phase 3

Longitudinal Study of Brain Amyloid imaGing in MEMENTO

Completed
NCT02120664Phase 1

Florbetapir Calibration to the Centiloid Scale

Completed
NCT01703702Phase 4

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

Completed
NCT02107599Phase 4

The Feasibility of Florbetapir Quantitation in Europe

Completed
NCT02029547Not Applicable

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

Withdrawn
NCT01890343Phase 2

Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.

Completed
NCT01660815Phase 1

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

Completed
NCT01662882Phase 2

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8